65 related articles for article (PubMed ID: 9293757)
1. [Contrast-associated nephrotoxicity: ultrastructural and biochemical study in diabetic rats].
Narasaki K
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Aug; 57(9):586-95. PubMed ID: 9293757
[TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity of contrast media assessed by occlusion arteriography.
Lund G; Rysavy J; Salomonowitz E; Cragg A; Vlodaver Z; Bendell W; Castaneda-Zuniga W; Amplatz K
Radiology; 1984 Sep; 152(3):615-9. PubMed ID: 6463242
[TBL] [Abstract][Full Text] [Related]
3. Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
Solomon R
Am Heart J; 2010 Feb; 159(2):e7; author reply e9. PubMed ID: 20152210
[No Abstract] [Full Text] [Related]
4. Comparative cytotoxicity of low- and high-osmolar contrast media to human fibroblasts and rat mesangial cells in culture.
Potier M; Lagroye I; Lakhdar B; Cambar J; Idee JM
Invest Radiol; 1997 Oct; 32(10):621-6. PubMed ID: 9342122
[TBL] [Abstract][Full Text] [Related]
5. Effect of water-soluble contrast medium on the lung in rats. Comparison of iotrolan, iopamidol, and diatrizoate.
Miyazawa T; Sho C; Nakagawa H; Oshino N
Invest Radiol; 1990 Sep; 25(9):999-1003. PubMed ID: 2211058
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural changes of kidney in diabetic rats.
Miko M; Jakubovsky J; Vrabcova M; Varga I
Bratisl Lek Listy; 2016; 117(3):161-5. PubMed ID: 26925747
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism.
Zhou S; Zhao P; Li Y; Deng T; Tian L; Li H
Eur J Pharmacol; 2014 Oct; 740():9-14. PubMed ID: 25008071
[TBL] [Abstract][Full Text] [Related]
8. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
[TBL] [Abstract][Full Text] [Related]
9. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.
Deepa B; Venkatraman Anuradha C
Toxicol Mech Methods; 2013 May; 23(4):223-34. PubMed ID: 23193997
[TBL] [Abstract][Full Text] [Related]
10. Ionic contrast media induced more apoptosis in diabetic kidney than nonionic contrast media.
Lee HC; Chang JG; Yen HW; Liu IH; Lai WT; Sheu SH
J Nephrol; 2011; 24(3):376-80. PubMed ID: 20890877
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
12. Acute effect of ionic high osmolar contrast medium on renal antioxidant enzyme activity in streptozotocin-induced diabetic rats.
Yen HW; Lee HC; Chuang HY; Lai WT; Sheu SH
Clin Exp Med; 2006 Jun; 6(2):94-8. PubMed ID: 16820998
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
[TBL] [Abstract][Full Text] [Related]
14. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
[TBL] [Abstract][Full Text] [Related]
15. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
16. Contrast media induced pulmonary edema. Comparison of ionic and nonionic agents in an animal model.
Måre K; Violante M; Zack A
Invest Radiol; 1984; 19(6):566-9. PubMed ID: 6511265
[TBL] [Abstract][Full Text] [Related]
17. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
[TBL] [Abstract][Full Text] [Related]
18. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
Bishnoi HK; Mahadevan N; Balakumar P
Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
[TBL] [Abstract][Full Text] [Related]
19. Contrast media-induced renal morphologic lesions in diabetic rats.
Tervahartiala P; Kivisaari L; Kivisaari R; Virtanen I
Acta Radiol; 1993 May; 34(3):220-5. PubMed ID: 8489833
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
